Novel Molecular Approaches to Anti-Inflammatory Therapy: Agents and Actions Supplements, cartea 46
Editat de Waldemar Pruzanski, Peter Vadasen Limba Engleză Paperback – 13 noi 2013
Din seria Agents and Actions Supplements
- Preț: 400.26 lei
- Preț: 387.38 lei
- Preț: 384.86 lei
- Preț: 381.98 lei
- Preț: 382.95 lei
- Preț: 388.52 lei
- Preț: 399.67 lei
- Preț: 392.60 lei
- Preț: 387.75 lei
- Preț: 381.43 lei
- Preț: 384.09 lei
- Preț: 390.63 lei
- Preț: 390.84 lei
- Preț: 388.52 lei
- Preț: 400.26 lei
- Preț: 397.01 lei
- 5% Preț: 393.58 lei
- Preț: 390.08 lei
- Preț: 386.61 lei
- Preț: 388.13 lei
- Preț: 392.37 lei
- 5% Preț: 721.19 lei
- 5% Preț: 366.91 lei
- Preț: 379.09 lei
- 5% Preț: 360.34 lei
- 5% Preț: 368.19 lei
Preț: 364.53 lei
Preț vechi: 383.71 lei
-5% Nou
Puncte Express: 547
Preț estimativ în valută:
69.76€ • 72.28$ • 58.22£
69.76€ • 72.28$ • 58.22£
Carte tipărită la comandă
Livrare economică 21 martie-04 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783034872782
ISBN-10: 303487278X
Pagini: 192
Ilustrații: VII, 183 p. 16 illus.
Dimensiuni: 170 x 244 x 10 mm
Greutate: 0.31 kg
Ediția:Softcover reprint of the original 1st ed. 1995
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Agents and Actions Supplements
Locul publicării:Basel, Switzerland
ISBN-10: 303487278X
Pagini: 192
Ilustrații: VII, 183 p. 16 illus.
Dimensiuni: 170 x 244 x 10 mm
Greutate: 0.31 kg
Ediția:Softcover reprint of the original 1st ed. 1995
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Agents and Actions Supplements
Locul publicării:Basel, Switzerland
Public țintă
ResearchCuprins
Eosinophil chemoattractants generated in vivo.- Chemokines and their role in human disease.- Structure/function analysis of human interleukin 5 and its receptor.- Potential phospholipase A2s involved in inflammatory diseases.- Mediation of inflammation by cyclooxygenase-2.- Secretory phospholipase A2 inhibitors. Possible new anti-inflammatory agents.- Recent insights into the structure, function and biology of cPLA2.- Control of inflammatory processes by cell-impermeable inhibitors of phospholipase A2.- Leukocyte adhesion and the anti-inflammatory effects of leukocyte integrin blockade.- ANTI-ICAM in inflammatory disease.- Complementary peptides as recognition molecules.- Nitric oxide-releasing NSAIDs: A novel class of GI-sparing anti-inflammatory drugs.- Anti-inflammatory lipocortin-derived peptides.- Inhibition of lipid mediator biosynthesis in human inflammatory cells by BIRM 270.- The use of anti-PECAM reagents in the control of inflammation.- Selective inhibitors of COX-2.- New frontiers in the pharmacotherapy of inflammation.